Embody vs Hers: Which GLP-1 Provider Is Better?
Embody’s GLP-1 website is joinem.co. GLP-1 Picks is an independent comparison site.
Short answer: Embody scores higher on our rubric, 7.3/10 against 5.3/10. Full reasoning, pricing and the cases where the other one wins are below.
Embody beats Hers overall, scoring 7.3/10 vs 5.3/10. Published pricing is not a like-for-like monthly comparison: Embody is from $69/mo; Hers is $188 first month, then $298/mo. Choose Embody for people comfortable committing to a term, since embody's cheapest rates are its twelve-month plans, and who want the commitment stated up front rather than implied. Choose Hers for women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path.
A side-by-side look at Embody and Hers to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Embody
#17 of 34Online weight-loss program that ships compounded GLP-1 medication to your door. Modern Metabolic Medicine, Inc. runs the storefront and OpenLoop Health supplies the clinical network on the current site. Embody now advertises compounded semaglutide from $79 and GLP-1 + GIP from $129; its FAQ says the chosen rate holds within a selected 4-, 12-, 24- or 52-week plan.
Visit EmbodyHers
#26 of 34The women's health arm of Hims & Hers Health (NYSE: HIMS). Hers lists Wegovy pill, Foundayo, and Ozempic pill medication from $149, a Wegovy pen from $199, Zepbound from $299, and compounded options. Wegovy and Foundayo carry FDA approval for weight management. Ozempic is FDA approved for type 2 diabetes and is prescribed off label for weight loss. A required Weight Loss Membership adds $39 in month one and $149/mo thereafter, so the all-in floor for a $149 medication path is $188 initially and $298/mo ongoing; exact product and dose prices vary.
Visit Hers| Feature | Embody | Hers |
|---|---|---|
| Why each one | Publishes a complete four-tier price ladder for both molecules, so the commitment behind every advertised rate is checkable rather than implied. | A major women-focused telehealth platform with a direct Novo Nordisk partnership (Wegovy pill from $149 and pen from $199 before required membership) and a Lilly partnership (Zepbound medication from $299) alongside compounded options. |
| Our Score | 7.3/10 | 5.3/10 |
| Headline Price | from $69/mo | $188 first month, then $298/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | People comfortable committing to a term, since Embody's cheapest rates are its twelve-month plans, and who want the commitment stated up front rather than implied | Women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path |
| Watch out for | Payments are normally non-refundable. If Embody's provider determines medical disqualification, its refund policy allows a refund for unused services after deducting services already provided. Cancellation otherwise stops future renewal. The twelve-month semaglutide plan commits $828 up front; cancellation requests must reach support at least 72 hours before the next billing date. | Pending federal enforcement against the parent company: on July 29, 2026 the FTC, joined by Utah and by California acting through Los Angeles County Counsel, sued Hims & Hers Health, Inc. in the Northern District of California over subscription billing, cancellation friction and sharing consumer health information with advertising platforms. The case status is Pending and these are allegations, not findings (checked 2026-09-03). |
| Ranking | #17 | #26 |
| Get started | Visit Embody | Visit Hers |
Pros & Cons Compared
Embody
Pros
- +Publishes a complete price ladder for both molecules, so what each advertised rate costs up front is checkable: semaglutide $79/$76/$73/$69 and tirzepatide $129/$126/$123/$119 across one, three, six and twelve months.
- +Advertised injection floors of $79 for semaglutide and $129 for GLP-1 + GIP, verified August 14, 2026. The FAQ says the selected rate holds within the chosen plan.
- +Four plan lengths are disclosed (4, 12, 24 and 52 weeks), giving shoppers a shorter-term option as well as longer-plan pricing.
- +Publishes its cancellation and refund terms in full, dated August 25, 2026, so the 72-hour cancellation cutoff and limited medical-disqualification refund exception are readable before you pay.
- +Replies to every negative Trustpilot review, usually within 24 hours.
Cons
- −Payments are normally non-refundable. If Embody's provider determines medical disqualification, its refund policy allows a refund for unused services after deducting services already provided. Cancellation otherwise stops future renewal. The twelve-month semaglutide plan commits $828 up front; cancellation requests must reach support at least 72 hours before the next billing date.
- −The advertised $69/$119 monthly rates require twelve months paid up front, at $828/$1,428. One-month plans are listed at $79/$129; cancellation normally stops renewal without refunding the paid term; medical disqualification has a limited refund exception.
- −Trustpilot rating is 3.7 / 5 across 6,825 reviews, checked 2026-09-03, while the landing page advertises 4.8. Price and billing remain recurring complaint themes, although many reviews describe earlier pricing structures.
- −Embody names four partner pharmacies: Red Rock Compounding Pharmacy in Utah, Health Warehouse in Kentucky, Precision Medicine in New York and Triad Rx in Alabama, and says all four are 503A compounding pharmacies. It does not say which one will fill your prescription. Triad Rx received a 2019 FDA warning letter for sterile-production violations, and the FDA close-out in May 2023 records that the firm no longer produces sterile drug products.
- −Compounded medications only, no brand-name Wegovy, Zepbound, Mounjaro, or Ozempic available.
- −Modern Metabolic Medicine, Inc. also runs SnagRx (snagrx.com) and RodeoMeds (rodeomeds.com). Each footer names the shared parent, but none of the three names the others, and SnagRx sells the same compounded semaglutide and tirzepatide at the same $69 and $119 prices Embody's own landing page shows. See our [SnagRx review](/reviews/snagrx)
Hers
Pros
- +Brand-name paths include Wegovy pill, Foundayo, and Ozempic pill medication from $149 and a Wegovy pen from $199. Wegovy and Foundayo carry FDA approval for weight management, Ozempic is approved for type 2 diabetes and is used off label here. With the required membership, a $149 medication path totals $188 initially and $298/mo ongoing
- +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services
Cons
- −Pending federal enforcement against the parent company: on July 29, 2026 the FTC, joined by Utah and by California acting through Los Angeles County Counsel, sued Hims & Hers Health, Inc. in the Northern District of California over subscription billing, cancellation friction and sharing consumer health information with advertising platforms. The case status is Pending and these are allegations, not findings (checked 2026-09-03).
- −Every medication figure excludes the required Weight Loss Membership ($39 first month, then $149/mo); exact product and dose prices can increase the total above the $188/$298 floor
- −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
- −Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
- −Zepbound medication starts at $299 before the required membership; that path totals $338 in month one and at least $448/mo ongoing, with exact dose pricing potentially higher
Our Verdict
Embody edges out Hers with a score of 7.3/10 vs 5.3/10. Published pricing is not a like-for-like monthly comparison: Embody is from $69/mo; Hers is $188 first month, then $298/mo. Hers offers both brand-name and compounded medications, giving you more flexibility.
Reviews and pricing sources
Related comparisons
More head-to-head comparisons involving Embody and Hers.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Compare Embody and Breeze Medsfrom $199/mo
- Compare Embody and Oak Longevityfrom $167/mo
- Compare Embody and Bodybuilding Health+$179/mo month-to-month
- Compare Hers and SkinnyRx$99 first month, rises after
- Compare Hers and Luvo Healthfrom $249/mo
- Compare Hers and Sesame Carepublished $99/mo; total not verified
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is Embody legit and is Hers legit, with the verification evidence behind each answer.
Our pick of these two: Embody · 7.3/10